We also look inside a new draft guidance from CDRH that would update the way software is documented in pre-market submissions.
Lastly, we distill some key points from a recent warning letter issued to…
Watch with a 7-day free trial
Subscribe to The FDA Group's Insider Newsletter to watch this video and get 7 days of free access to the full post archives.